Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the efficacy and safety of YM672 administered orally in the treatment of painful bladder syndrome (PBS)/interstitial cystitis (IC). The primary efficacy endpoint is success, defined as ‘Moderately Improved’ or ‘Markedly Improved’ PBS/IC on the subject-rated 7-point Global Response Assessment (GRA) at the Week 12 and/or End of Treatment (ET) visit.
Inclusion criteria
- Interstitial Cystitis / Painful Bladder Syndrome